Latest filing published 08 Jun 2026 for Evolent Health, Inc..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Russell Monroe Glass in Evolent Health, Inc. Over a trading history stretching from 1 March 2024 to 4 June 2026, the count stands at 5 filings.
Every open-market trade on record is a purchase: 1 purchase worth €46k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants.
On 8 June 2026 came the latest disclosure, a share grant in Evolent Health, Inc. The last insider purchase was made public on 10 March 2025, 595 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations